Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.

Cancer research communications - 1 Oct 2024

Heath Elisabeth, Dyson Gregory, Ribeiro Jennifer R, Xiu Joanne, Poorman Kelsey, Mamdani Hirva, Al-Hallak Mohammed N, Shields Anthony F, Elayoubi Jailan A, Winer Ira S, Cackowski Frank C, Puckrein Gary A, Lopes Gilberto de Lima, Jones Nathaniel, Hauke Ralph J, Kareff Samuel A, Radovich Milan, Sledge George W, Spetzler David B, Vidal Gregory A, Marshall John L

Abstract excerpt

Health disparities present a barrier to successful oncology treatment. The potential for precision oncology to reduce health disparities has not previously been analyzed. We performed a retrospective analysis of 12,627 patients from six major cancer centers whose tumors underwent molecular testing at Caris Life Sciences between 2010 and 2020. Kaplan-Meier and Cox regression were used to describe and analyze...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Health Status Disparities

Share to Healthcare Disparities

Share to Molecular Targeted Therapy

Share to Mutation

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 39172022
DOI: 10.1158/2767-9764.CRC-24-0321
PMCID: PMC11450693

Genes

APC
EGFR
KRAS
STK11
TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.PMID 39172022Read ↗

Pan-Cancer Analyses Reveal Disparities in Tumor Genomic Profiles by Race/Ethnicity, Age, and SexSemantic proximity Read ↗

The Role of Race and Insurance Status in Access to Genetic Counseling and Testing Among High-Risk Breast Cancer PatientsSemantic proximity Read ↗

Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer.Semantic proximity Read ↗

Next-Generation Sequencing Trends among Adult Patients with Select Advanced Tumor Types: A Real-World Evidence Evaluation.Semantic proximity Read ↗

Racial disparities in patient survival and tumor mutation burden, and the association between tumor mutation burden and cancer incidence rate.Semantic proximity Read ↗

Biomarker Testing Disparities in Metastatic Colorectal CancerSemantic proximity Read ↗

Racial/Ethnic Disparities in Genomic SequencingSemantic proximity Read ↗

Widespread adoption of precision anticancer therapies after implementation of pathologist-directed comprehensive genomic profiling across a large US health systemSemantic proximity Read ↗

Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019Semantic proximity Read ↗

Tumor Molecular Profiling in Hispanics: Moving Towards Precision Oncology and Health Equity.Semantic proximity Read ↗

Racial Differences in Stage IV Colorectal Cancer Molecular Profiling and Mutation Rates.Semantic proximity Read ↗

Investigating racial disparities in carcinomas through TCGA transcriptomic and proteomic databaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.